Method for treating coumarin-induced hemorrhage
AssigneeZymoGenetics, Inc.
InventorPaul D. Bishop
Life of this patent
Estimating the term…
Abstract
Use of factor XIII for treating coumarin-induced hemorrhage or bleeding. The coumarin may be warfarin or dicoumarol. A patient having coumarin-induced bleeding is treated with factor XIII alone or in conjunction with vitamin K.
Claims7
A method for inhibiting coumarin anticoagulant-induced bleeding or hemorrhage in an individual comprising administering to the individual a therapeutically effective amount of a composition comprising factor XIII as the sole active agent.
A method for inhibiting coumarin anticoagulant-induced bleeding or hemorrhage in an individual comprising administering to the individual a therapeutically effective amount of a first composition comprising factor XIII as the sole active agent and a second composition comprising vitamin K.
Dependencies are inferred from the claim text.